Martinus Capelle
Drug Product Development & Delivery, Distinguished Scientist Johnson & Johnson
Martinus Capelle is working at Johnson & Johnson Innovative Medicine as Distinguished Scientist II in the global Drug Product Development & Delivery organization. He is an innovative Drug Product leader and CMC strategist with ~25 years of experience across pre‑clinical to late‑stage development and launch. Expertise spans formulation, biopharmaceutics, advanced analytical development, fill/finish, and manufacturing of biologics, including peptides, proteins, multi-specific mAbs, vaccines, viral, cell-gene therapies and RNA‑LNPs. Holds a PhD in Pharmaceutical Technology (University of Geneva); previously collaborated with multiple biotech/pharma companies at Therapeomic (CRO, Basel) and has held roles of increasing responsibility at J&J since 2012.
Seminars
- Exploring how tumour models can better replicate the practical realities of intratumoral dosing, distribution, and therapeutic exposure within solid tumours
- Evaluating strategies to optimise local delivery, injection approaches, and formulation design to maintain drug stability and activity within the tumour microenvironment
- Sharing future plans from the SPARC consortium on developing scalable approaches, including tumour on chips, to convert immunologically cold tumours into hot tumours that are responsive to antibody and immune-based therapies
- Which aspects of the tumour microenvironment remain most difficult to capture?
- How can advanced models be made more scalable and reproducible?
- What innovations will have the biggest impact on model relevance over the next five years?
- Audience Q&As
